Opportunities abound to develop and implement actionable strategies that will increase and diversify enrollment in clinical trials, safeguard participants, strengthen efficacy, and translate evidence into meaningful benefits for individuals, families, and communities in the United States and around the world. LEAD Coalition Executive Director Ian Kremer wrote to the National Institute on Aging to propose a range of specific actions and to call for genuine, candid, persistent, inclusive collaboration by all stakeholders. Read the letter.
LEAD Responds to National Institute on Aging Request for Information About Improving Alzheimer’s Disease Clinical Trials
